dacarbazine and thymosin

dacarbazine has been researched along with thymosin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ameglio, F; Carpano, S; Cavaliere, R; Di Lauro, L; Frasca, AM; Lopez, M; Pignatti, F; Rosselli, M; Vici, P; Vitelli, G1
Garaci, E; Izzo, F; Pierimarchi, P; Ranuzzi, M; Rasi, G; Sinibaldi-Vallebona, P; Terzoli, E; Tuthill, C1
Camerini, R; Cognetti, F; Ferraresi, V; Garbe, C; Gascon, P; Gilde, K; Guillot, B; Jassem, J; Lesimple, T; Mackiewicz, A; Maio, M; Testori, A; Trefzer, U1
Calabrò, L; Danielli, R; Di Giacomo, AM; Fonsatti, E; Maio, M1

Reviews

1 review(s) available for dacarbazine and thymosin

ArticleYear
Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond.
    Annals of the New York Academy of Sciences, 2012, Volume: 1270

    Topics: Antineoplastic Agents, Alkylating; Clinical Trials, Phase II as Topic; Dacarbazine; Humans; Immunologic Factors; Immunotherapy; Melanoma; Randomized Controlled Trials as Topic; Thymosin

2012

Trials

3 trial(s) available for dacarbazine and thymosin

ArticleYear
Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:8

    Topics: Adult; Aged; CD4 Antigens; CD8 Antigens; Combined Modality Therapy; Dacarbazine; Female; Humans; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Remission Induction; Skin Neoplasms; Thymalfasin; Thymosin

1994
Combined treatment with thymosin-alpha1 and low dose interferon-alpha after dacarbazine in advanced melanoma.
    Melanoma research, 2000, Volume: 10, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Feasibility Studies; Female; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Killer Cells, Natural; Lymphopenia; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Safety; Survival Analysis; Thymalfasin; Thymosin; Treatment Outcome

2000
Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Apr-01, Volume: 28, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Interferon-alpha; Male; Melanoma; Middle Aged; Thymalfasin; Thymosin

2010